charles eberhart

charles eberhart

Johns Hopkins University

H-index: 105

North America-United States

About charles eberhart

charles eberhart, With an exceptional h-index of 105 and a recent h-index of 68 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Neuropathology, Ophthalmic Pathology, Cancer, Notch signalling.

His recent articles reflect a diverse array of research interests and contributions to the field:

An unusual finding of an anaplastic meningioma in NF2-related schwannomatosis

Selective inhibition of the CoREST complex as a novel therapeutic target of atypical teratoid rhabdoid tumors

Integrated in vitro and machine learning approaches for targeted drug screening in gliomas with concurrent NF1 and ATRX loss

Collagen type XII is undetectable in keratoconus Bowman’s layer

DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologically

MEK inhibitor mirdametinib suppresses MAP kinase pathway activity and inhibits tumor growth in atypical teratoid/rhabdoid tumors

Improving survival of atypical teratoid/rhabdoid tumor orthotopic xenografts through the combination of PI3K inhibitor paxalisib and nucleoside analog gemcitabine

Older Woman With Proptosis, Ptosis, and Blurred Vision

charles eberhart Information

University

Position

Professor of Pathology Ophthalmology and Oncology School of Medicine

Citations(all)

46045

Citations(since 2020)

18695

Cited By

35081

hIndex(all)

105

hIndex(since 2020)

68

i10Index(all)

351

i10Index(since 2020)

284

Email

University Profile Page

Johns Hopkins University

Google Scholar

View Google Scholar Profile

charles eberhart Skills & Research Interests

Neuropathology

Ophthalmic Pathology

Cancer

Notch signalling

Top articles of charles eberhart

Title

Journal

Author(s)

Publication Date

An unusual finding of an anaplastic meningioma in NF2-related schwannomatosis

Child's Nervous System

Siegfried J Adelhoefer

James Feghali

Sharika Rajan

Charles G Eberhart

Verena Staedtke

...

2024/3/7

Selective inhibition of the CoREST complex as a novel therapeutic target of atypical teratoid rhabdoid tumors

Cancer Research

Anupa Geethadevi

Marianne Collard

Tyler Findlay

Yiming Deng

Robert Fisher

...

2024/3/22

Integrated in vitro and machine learning approaches for targeted drug screening in gliomas with concurrent NF1 and ATRX loss

Cancer Research

Swati Dubey

Somesh Mohapatra

Ming Yuan

Charles G Eberhart

Fausto J Rodriguez

2024/3/22

Collagen type XII is undetectable in keratoconus Bowman’s layer

British Journal of Ophthalmology

Mohammed Rigi

Hyeck-Soo Son

Loren Moon

Mario Matthaei

Divya Srikumaran

...

2024/3/1

DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologically

Neuro-Oncology Advances

Ashley R Tetens

Allison M Martin

Antje Arnold

Orlandi V Novak

Adrian Idrizi

...

2024/2/19

MEK inhibitor mirdametinib suppresses MAP kinase pathway activity and inhibits tumor growth in atypical teratoid/rhabdoid tumors

Cancer Research

Yiming Deng

Kristen Malebranche

Tyler Findlay

Anupa Geethadevi

Charles Eberhart

...

2024/3/22

Improving survival of atypical teratoid/rhabdoid tumor orthotopic xenografts through the combination of PI3K inhibitor paxalisib and nucleoside analog gemcitabine

Cancer Research

Tyler Findlay

Kristen Malebranche

Anupa Geethadevi

Charles Eberhart

Jeffrey Rubens

...

2024/3/22

Older Woman With Proptosis, Ptosis, and Blurred Vision

JAMA ophthalmology

Alison B Gibbons

Charles Eberhart

Emily Li

2024/1/25

Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model

Acta Neuropathologica Communications

Sanghee Lim

Minhye Kwak

Jeonghan Kang

Melissa Cesaire

Kayen Tang

...

2024/4/8

Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity

CNS oncology

Edina Komlodi-Pasztor

Vasu Munjapara

Charles G Eberhart

Danielle A Bazer

Mohamed R Sherief

...

2024/3/8

Frontal lobe mass in a 46‐year‐old woman

Brain Pathology

Kevin Y Zhang

Bharat Ramlal

Karisa C Schreck

Charles G Eberhart

Calixto‐Hope G Lucas

2024/1

A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX, and MYC that promotes group 3 medulloblastoma

Cell Reports

Keisuke Katsushima

Kandarp Joshi

Menglang Yuan

Brigette Romero

Mona Batish

...

2024/3/26

BIOL-13. DEPLOYING NEW MODELS OF NF-1 MUTANT LOW GRADE GLIOMA TO ACCELERATE THERAPEUTIC DEVELOPMENT

Neuro-Oncology

Lujain Alaali

Jinchong Xu

Jeff Mumm

Ming Yuan

Charles Eberhart

...

2023/6

The PI3K inhibitor Paxalisib combines synergistically with the MEK inhibitor Mirdametinib to target atypical teratoid/rhabdoid tumors

Cancer Research

Kristen J Malebranche

Tyler Findlay

Anupa Geethadevi

Charles Eberhart

Eric Raabe

...

2023/4/4

“Groove and Peel” Deep Anterior Lamellar Keratoplasty: How Deep Can You Go?

Cornea

Hyeck-Soo Son

Mohammed Rigi

Divya Srikumaran

Charles G Eberhart

Albert S Jun

...

2023/1/1

Mouse and human Retinal Pigment Epithelium express GPR81 receptors

Investigative Ophthalmology & Visual Science

Elyse Blank

Cornelia W Peterson

Vishal Shinde

Antionette Price

Charles G Eberhart

...

2023/6/1

Orbital SOX10-mutant schwannoma with plexiform growth: Expanding the histopathological spectrum of a new molecular group

Journal of Neuropathology & Experimental Neurology

Ansar A Wali

Robin Yang

Shannath L Merbs

Fausto J Rodriguez

Charles G Eberhart

...

2023/11/1

miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4

Acta Neuropathologica Communications

Menglang Yuan

Iqbal Mahmud

Keisuke Katsushima

Kandarp Joshi

Olivier Saulnier

...

2023/12/19

Combination of the PI3k inhibitor Paxalisib with the nucleoside analog Gemcitabine over-activates the integrated stress response and induces atypical teratoid/rhabdoid tumor …

Cancer Research

Tyler Findlay

Kristen Malebranche

Anupa Geethadevi

Eric Raabe

Charles Eberhart

...

2023/4/4

Upregulated MYC expression and p53 mutations may contribute to the oncogenesis of canine Meibomian gland carcinomas

Veterinary pathology

Cornelia Peterson

JL Hicks

AM De Marzo

AA Campbell

CG Eberhart

...

2023/3

See List of Professors in charles eberhart University(Johns Hopkins University)

Co-Authors

H-index: 140
Peter Burger

Peter Burger

Johns Hopkins University

H-index: 128
Angelo M. De Marzo M.D., Ph.D.

Angelo M. De Marzo M.D., Ph.D.

Johns Hopkins University

H-index: 120
Arie Perry

Arie Perry

University of California, San Francisco

H-index: 106
Keith L. Ligon

Keith L. Ligon

Harvard University

H-index: 81
Scott L. Pomeroy

Scott L. Pomeroy

Harvard University

H-index: 64
Fausto Rodriguez

Fausto Rodriguez

Johns Hopkins University

academic-engine